"Were passing that access and value along to our customers, who deserve the highest standard of clinical safety and efficacy to meet their goals, and we're doing it in a safe, affordable way that others cant deliver." Hims & Hers stock surged more than 27% to a three-year high following the news
Users and advisors often view protein support as one of the clearest nutritional priorities during GLP-1 use, especially where muscle preservation and satiety matter
Its important to remember that these drugs are expensive and more cost-effective treatments already exist, particularly for opioid use disorder, Varisco says
Check them out on LinkedIn
Since this was an observational study, this association does not prove causality
Some of that gap reflects cost and access barriers that policymakers are still working through